Vimarsana.com

Latest Breaking News On - Samuel durand professor - Page 1 : vimarsana.com

Relapsed DLBCL: Complete Interim Response, SCT Beats CAR T

'In patients with relapsed DLBCL in a complete remission, treatment with auto-HCT is associated with a lower rate of relapse/progression, and a longer progression-free survival [versus CAR T therapy].'

San-diego
California
United-states
New-york
University-of-rochester
American
Morphosys-incyte
Mazyar-shadman
Jonathanw-friedberg
Bristol-myers-squibb
American-society-of-hematology
International-blood-marrow-transplant-research

vimarsana © 2020. All Rights Reserved.